| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |